deltatrials
Recruiting PHASE3 INTERVENTIONAL 4-arm NCT05067634

Safety and Efficacy Study of Cenobamate in Pediatric Subjects 2-17 Years of Age With Partial-onset (Focal) Seizures

Open-Label Safety and Efficacy Study of Cenobamate in Pediatric Subjects 2-17 Years of Age With Partial-onset (Focal) Seizures

Sponsor: SK Life Science, Inc.

Interventions Xcopri
Updated 28 times since 2021 Last updated: Sep 17, 2025 Started: Jan 14, 2022 Primary completion: May 31, 2026 Completion: Jul 31, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Partial Epilepsy, this trial is actively recruiting participants. The trial is conducted by SK Life Science, Inc. and has accumulated 28 data snapshots since 2022. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Nov 2021 – ~Dec 2021 · 30 days · monthly snapshot~Dec 2021 – ~Mar 2022 · 3 months · monthly snapshot~Mar 2022 – ~May 2022 · 2 months · monthly snapshot~May 2022 – ~Jul 2022 · 2 months · monthly snapshot~Jul 2022 – ~Sep 2022 · 2 months · monthly snapshot~Sep 2022 – ~Nov 2022 · 2 months · monthly snapshot~Nov 2022 – ~Jan 2023 · 2 months · monthly snapshot~Jan 2023 – ~Mar 2023 · 59 days · monthly snapshot~Mar 2023 – ~Apr 2023 · 31 days · monthly snapshot~Apr 2023 – ~May 2023 · 30 days · monthly snapshot~May 2023 – ~Jun 2023 · 31 days · monthly snapshot~Jun 2023 – ~Jul 2023 · 30 days · monthly snapshot~Jul 2023 – ~Aug 2023 · 31 days · monthly snapshot~Aug 2023 – ~Sep 2023 · 31 days · monthly snapshot~Sep 2023 – ~Oct 2023 · 30 days · monthly snapshot~Oct 2023 – ~Nov 2023 · 31 days · monthly snapshot~Nov 2023 – ~Dec 2023 · 30 days · monthly snapshot~Dec 2023 – ~Jan 2024 · 31 days · monthly snapshot~Jan 2024 – ~Feb 2024 · 31 days · monthly snapshot~Feb 2024 – ~Jul 2024 · 5 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Jan 2025 · 4 months · monthly snapshot~Jan 2025 – ~Apr 2025 · 3 months · monthly snapshot~Apr 2025 – ~Jul 2025 · 3 months · monthly snapshot~Jul 2025 – ~Aug 2025 · 31 days · monthly snapshot~Aug 2025 – ~Sep 2025 · 31 days · monthly snapshot~Sep 2025 – ~Oct 2025 · 30 days · monthly snapshot~Oct 2025 – present · 10 months · monthly snapshot

Change History

28 versions recorded
  1. Oct 2025 — Present [monthly]

    Recruiting PHASE3

  2. Sep 2025 — Oct 2025 [monthly]

    Recruiting PHASE3

  3. Aug 2025 — Sep 2025 [monthly]

    Recruiting PHASE3

  4. Jul 2025 — Aug 2025 [monthly]

    Recruiting PHASE3

  5. Apr 2025 — Jul 2025 [monthly]

    Recruiting PHASE3

Show 23 earlier versions
  1. Jan 2025 — Apr 2025 [monthly]

    Recruiting PHASE3

  2. Sep 2024 — Jan 2025 [monthly]

    Recruiting PHASE3

  3. Jul 2024 — Sep 2024 [monthly]

    Recruiting PHASE3

  4. Feb 2024 — Jul 2024 [monthly]

    Recruiting PHASE3

  5. Jan 2024 — Feb 2024 [monthly]

    Recruiting PHASE3

  6. Dec 2023 — Jan 2024 [monthly]

    Recruiting PHASE3

  7. Nov 2023 — Dec 2023 [monthly]

    Recruiting PHASE3

  8. Oct 2023 — Nov 2023 [monthly]

    Recruiting PHASE3

  9. Sep 2023 — Oct 2023 [monthly]

    Recruiting PHASE3

  10. Aug 2023 — Sep 2023 [monthly]

    Recruiting PHASE3

  11. Jul 2023 — Aug 2023 [monthly]

    Recruiting PHASE3

  12. Jun 2023 — Jul 2023 [monthly]

    Recruiting PHASE3

  13. May 2023 — Jun 2023 [monthly]

    Recruiting PHASE3

  14. Apr 2023 — May 2023 [monthly]

    Recruiting PHASE3

    Status: Active Not RecruitingRecruiting

  15. Mar 2023 — Apr 2023 [monthly]

    Active Not Recruiting PHASE3

  16. Jan 2023 — Mar 2023 [monthly]

    Active Not Recruiting PHASE3

  17. Nov 2022 — Jan 2023 [monthly]

    Active Not Recruiting PHASE3

  18. Sep 2022 — Nov 2022 [monthly]

    Active Not Recruiting PHASE3

  19. Jul 2022 — Sep 2022 [monthly]

    Active Not Recruiting PHASE3

    Status: RecruitingActive Not Recruiting

  20. May 2022 — Jul 2022 [monthly]

    Recruiting PHASE3

  21. Mar 2022 — May 2022 [monthly]

    Recruiting PHASE3

    Status: Not Yet RecruitingRecruiting

  22. Dec 2021 — Mar 2022 [monthly]

    Not Yet Recruiting PHASE3

  23. Nov 2021 — Dec 2021 [monthly]

    Not Yet Recruiting PHASE3

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • SK Life Science, Inc.
Data source: SK Life Science, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .